BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of ethambutol in chronic pulmonary tuberculosis]. 1972

V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females

Related Publications

V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
January 1972, Problemy tuberkuleza,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
Treatment of chronic pulmonary tuberculosis with ethambutol.
January 1971, Giornale italiano delle malattie del torace,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Ethambutol in the treatment of chronic pulmonary tuberculosis].
January 1970, Plucne bolesti i tuberkuloza,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
Ethambutol in the retreatment of chronic pulmonary tuberculosis.
April 1970, British journal of diseases of the chest,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
January 1968, Giornale italiano delle malattie del torace,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
January 1973, Scandinavian journal of respiratory diseases,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
January 1973, Problemy tuberkuleza,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
June 1980, Problemy tuberkuleza,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
Ethambutol in the treatment of patients with chronic pulmonary tuberculosis.
February 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
V Golli, and E Stefanin, and P Chiper, and I Stefănescu, and I M Popescu-Crivina, and E Anghel, and E Kosinski, and A Daha, and M Kosinski, and N Floricel
[Ethambutol and pulmonary tuberculosis].
June 1969, El Torax,
Copied contents to your clipboard!